Acquiring Company
Sun Pharmaceutical Industries
Acquired Company
Taro Pharmaceutical Industries
Mumbai
New YorkBiotechnologyHealth CarePharmaceuticalManufacturingBiotechnologyPharmaceuticalDescription
Sun Pharmaceutical Industries has announced the acquisition of Taro Pharmaceutical Industries, with a cash merger priced at USD 32.25 per share. The deal concludes Taro's independent listing and secures a cash payout for existing shareholders. This strategic move aligns with Sun Pharma's efforts to streamline its corporate structure and reduce complexity. The merger is set to finalize on September 17, 2026.
Don't miss Sun Pharmaceutical Industries's next move
Get an email the moment Sun Pharmaceutical Industries makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries was acquired by Sun Pharmaceutical Industries, based in Mumbai. The deal was reported on September 17, 2026. Sun Pharmaceutical Industries is a global pharmaceutical company based in India. It specializes in providing high-quality medicines across various therapeutic areas, including oncology. Sun Pharmaceutical Industries is privately held and operates in Biotechnology.
When did Sun Pharmaceutical Industries acquire Taro Pharmaceutical Industries?
Sun Pharmaceutical Industries's acquisition of Taro Pharmaceutical Industries was reported on September 17, 2026. Sun Pharmaceutical Industries has announced the acquisition of Taro Pharmaceutical Industries, with a cash merger priced at USD 32.25 per share. The deal concludes Taro's independent listing and secures a cash payout for existing shareholders. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Taro Pharmaceutical Industries do?
Taro Pharmaceutical Industries is a specialty pharmaceutical company focused on dermatology and other therapeutic areas. It develops, manufactures, and markets pharmaceutical products for human use. It is privately held, operating in Manufacturing, and is based in New York.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.